注射用脑蛋白水解物(Ⅰ)与(Ⅱ)治疗脑梗死恢复期患者的医疗费用和住院天数比较  

Comparison of Medical Expenses and Hospitalization Days Between Cerebroprotein Hydrolysate(Ⅰ)and(Ⅱ)Injection in Patients with Cerebral Infarction During Convalescence

作　　者：肖若薇 朱贺 李薇 史录文[1,2] 韩晟[1,2] XIAO Ruo-wei;ZHU He;LI Wei;SHI Lu-wen;HAN Sheng(International Research Center for Medicinal Administration,Peking University,Beijing 100191,China;School of Pharmaceutical Sciences,Peking University,Beijing 100191,China)

机构地区：[1]北京大学医药管理国际研究中心,北京100191 [2]北京大学药学院,北京100191

出　　处：《医学信息》2022年第14期95-98,共4页Journal of Medical Information

摘　　要：目的比较注射用脑蛋白水解物(Ⅰ)与(Ⅱ)治疗脑梗死恢复期患者的医疗费用和住院天数的差异。方法通过河北省某三级医院2017年3月25日-2019年3月26日合理用药调研数据选取206例脑梗死恢复期患者,根据使用的注射用脑蛋白水解物类型分成注射用脑蛋白水解物(Ⅰ)组和注射用脑蛋白水解物(Ⅱ)组,各103例,比较两组的医疗费用和住院天数。结果两组次均处方费用、次均床位费、次均护理费及次均中药费比较,差异无统计学意义(P>0.05);注射用脑蛋白水解物(Ⅱ)组次均住院总费用、次均治疗费、次均检查费、次均其他费用及次均住院天数少于注射用脑蛋白水解物(Ⅰ)组,差异有统计学意义(P<0.05)。结论使用注射用脑蛋白水解物(Ⅰ)与(Ⅱ)治疗的脑梗死恢复期患者在次均处方费用方面基本一致,但使用注射用脑蛋白水解物(Ⅱ)治疗的患者的次均住院总费用较低,次均住院天数较短。Objective To compare the differences of medical expenses and hospitalization days between injection of cerebroprotein hydrolysate(Ⅰ)and(Ⅱ)in patients with cerebral infarction during convalescence.Methods A total of 206 patients with cerebral infarction in recovery period were selected from the survey data of rational drug use in a tertiary hospital in Hebei Province from March 25,2017 to March 26,2019.According to the type of brain protein hydrolysate used for injection,the patients were divided into injection brain protein hydrolysate(Ⅰ)group and injection brain protein hydrolysate(Ⅱ)group,with 103 cases in each group.The medical costs and hospitalization days of the two groups were compared.Results There was no significant difference in prescription cost,bed cost,nursing cost and Chinese medicine cost between the two groups(P>0.05).The total cost of hospitalization,the average treatment cost,the average examination cost,the average other cost and the average length of stay in the injection brain protein hydrolysate(Ⅱ)group were less than those in the injection brain protein hydrolysate(Ⅰ)group,and the difference was statistically significant(P<0.05).Conclusion The average prescription costs of patients with cerebral infarction at recovery stage treated with injection of cerebroprotein hydrolysates(Ⅰ)and(Ⅱ)are basically the same,but the average hospitalization costs of patients treated with injection of cerebroprotein hydrolysates(Ⅱ)are lower and the average hospitalization days are shorter.

关 键 词：脑梗死恢复期 注射用脑蛋白水解物 医疗费用 住院天数 

分 类 号：R956[医药卫生—药学]